Biotron is developing first-in-class drugs to serious viral diseases. Its lead compound BIT225 is in Phase 2 trials for treatment of HIV and Hepatitis C virus.

ID: 2152734840

linkhttp://www.biotron.com.au calendar_today24-10-2013 10:58:21